REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024).
- 1Clínica Scope, Centro de Doenças Inflamatórias Intestinais, Campo Grande, MS, Brasil.
- 2Universidade Anhanguera-Uniderp, Campo Grande, MS, Brasil.
- 3Universidade Federal de Mato Grosso do Sul, Instituto de Química, Campo Grande, MS, Brasil.
Abstract
Background
Inflammatory bowel diseases (Crohn's and Ulcerative colitis) have been increasing alarmingly in Brazil. They affect mainly young people at reproductive age, which is extremely worrying in such a young country. To date, there´s no study that demonstrates how these diseases can affect pregnant women, like drug side effects and how off-springs of Brazilian patients evolve over time.Objectives
The study aimed to analyze the side effects of medications used by patients with Inflammatory Bowel Disease (IBD) during pregnancy; to assess the impact of disease activity on the course of pregnancy and fetal development and to monitor the development of these children.Methods
This was a longitudinal retrospective analysis of patients registered over time (2007/2024), regarding the medications used during the conception, side effects, complications during pregnancy and post-delivery. All patients were recruited at the Inflammatory Bowel Disease service at Scope Clinic, located in the Midwest region of Brazil.Results
Out of the 329 patients, 25 got pregnant (mean age 30.38 years), 48% were in endoscopic activity and 52% were in remission at conception time, and all patients maintained prescribed medication (chimeric and fully human anti-TNF agents, as well as immunosuppressive medications). Disease activity had direct influence on the babies' weight and on the Apgar score when compared to women in remission, but despite this fact, prematurity was not observed. No undesirable drug effects were observed in both groups (mother and fetus), endorsing their safety over this population. In the postpartum follow-up over a period of two years, no abnormalities were observed.Conclusion
This study shows the importance of continuously monitoring patients with inflammatory disease and guiding them on drug maintenance and the most appropriate time for conception.
Related
- Beyond the Bowel: A Narrative Review Examining Bidirectional Mental Health Pathways Across Disorders of Gut-Brain Interaction and Inflammatory Bowel Disease
- Alternative Medicine and Nutritional Therapy in Adult Inflammatory Bowel Disease in India: A Move Towards Holistic Practice
- Human immunodeficiency virus infection mimicking very early onset inflammatory bowel disease
- PD-1 and PD-L1 Expression in Inflammatory Bowel Disease: A Paired Immunohistochemical Study
- Mapping mitochondria-associated research in inflammatory bowel disease : A bibliometric and network analysis
BibTeX
@article{cury2026reality,
title = {{REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024).}},
author = {Didia Bismara Cury and Liana Cristina Bismara Cury and Ana Camila Micheletti},
journal = {Arquivos de gastroenterologia},
year = {2026},
month = oct,
doi = {10.1590/s0004-2803.24612026-009},
url = {https://europepmc.org/article/MED/42961249},
note = {CC BY},
}
RIS
TY - JOUR
TI - REALITY OF INFLAMMATORY BOWEL DISEASE IN BRAZILIAN PREGNANT WOMEN (2007/2024).
AU - Didia Bismara Cury
AU - Liana Cristina Bismara Cury
AU - Ana Camila Micheletti
PY - 2026
DA - 2026/10/26
JO - Arquivos de gastroenterologia
DO - 10.1590/s0004-2803.24612026-009
UR - https://europepmc.org/article/MED/42961249
AB - Background Inflammatory bowel diseases (Crohn's and Ulcerative colitis) have been increasing alarmingly in Brazil. They affect mainly young people at reproductive age, which is extremely worrying in such a young country. To date, there´s no study that demonstrates how these diseases can affect pregnant women, like drug side effects and how off-springs of Brazilian patients evolve over time.Objectives The study aimed to analyze the side effects of medications used by patients with Inflammatory Bowel Disease (IBD) during pregnancy; to assess the impact of disease activity on the course of pregnancy and fetal development and to monitor the development of these children.Methods This was a longitudinal retrospective analysis of patients registered over time (2007/2024), regarding the medications used during the conception, side effects, complications during pregnancy and post-delivery. All patients were recruited at the Inflammatory Bowel Disease service at Scope Clinic, located in the Midwest region of Brazil.Results Out of the 329 patients, 25 got pregnant (mean age 30.38 years), 48% were in endoscopic activity and 52% were in remission at conception time, and all patients maintained prescribed medication (chimeric and fully human anti-TNF agents, as well as immunosuppressive medications). Disease activity had direct influence on the babies' weight and on the Apgar score when compared to women in remission, but despite this fact, prematurity was not observed. No undesirable drug effects were observed in both groups (mother and fetus), endorsing their safety over this population. In the postpartum follow-up over a period of two years, no abnormalities were observed.Conclusion This study shows the importance of continuously monitoring patients with inflammatory disease and guiding them on drug maintenance and the most appropriate time for conception.
SN - 0004-2803
SN - 1678-4219
ER -